SCIENTIFIC BACKGROUND

ABCB7, ABHD12, ADGRG1, AFG3L2, AHI1, AMACR, ARL13B, ARSA, ATCAY, ATM, ATP1A3, ATP8A2, ATXN10, BTD, CA8, CAPN1, CC2D2A, CEP290, CEP41, CLCN2, CLN5, CLN6, COQ8A, CP, CPLANE1, CSPP1, CYP27A1, DARS2, DLAT, DNAJC19, DNMT1, FLVCR1, GALC, GBA, GBA2, GJB1, GOSR2, INPP5E, KIAA0586, KIF1C, KIF7, MARS2, MRE11, MTPAP, NPC1, NPC2, NPHP1, OFD1, OPA1, OPA3, PANK2, PDE10A, PDE6D, PEX10, PEX2, PLA2G6, PNPLA6, POC1B, POLG, POLR3A, RPGRIP1L, SACS, SIL1, SLC17A5, SPG7, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, VAMP1, VLDLR, WFS1, ZNF423

Scientific background

  • 3-methylglutaconic aciduria, type III (OPA3, AR)
  • 3-Methylglutaconic aciduria, type V (DNAJC19, AR)
  • Alpha-methylacyl-CoA racemase deficiency (AMACR, AR)
  • Anemia, sideroblastic, with ataxia (ABCB7, XL)
  • Ataxia telangiectasia (ATM, AR)
  • Ataxia telangiectasia-like disease (MRE11, AR)
  • Ataxia, autosomal recessive (PEX10, AR)
  • Ataxia, cerebellar, Cayman type (ATCAY, AR)
  • Behr syndrome (OPA1, AR)
  • Biotinidase deficiency (BTD, AR)
  • Boucher-Neuhauser syndrome (PNPLA6, AR)
  • CAPOS syndrome (ATP1A3, AD)
  • Cerebellar ataxia (CP, AR)
  • Cerebellar ataxia and mental retardation (CA8, AR)
  • Cerebellar ataxia and mental retardation 4 (?) (ATP8A2, AR)
  • Cerebellar ataxia with spasticity (GBA2, AR)
  • Cerebellar ataxia, deafness and narcolepsy, autosomal dominant (DNMT1, AD)
  • Cerebellar hypoplasia and mental retardation (VLDLR, AR)
  • Cerebrotendinous xanthomatosis (CYP27A1, AR)
  • Charcot-Marie-Tooth neuropathy, X-dominant, 1 (GJB1, XLD)
  • Epilepsy, progressive, myoclonic 6 (GOSR2, AR)
  • Gaucher disease type III (GBA, AR)
  • Infantile-onset limb and orofacial dyskinesia (PDE10A, AR)
  • Joubert syndrome phenotype (POC1B, AR)
  • Joubert syndrome type 1 (INPP5E, AR)
  • Joubert syndrome type 10 (OFD1, XLR)
  • Joubert syndrome type 11 (TTC21B, AR)
  • Joubert syndrome type 12 (KIF7, AR)
  • Joubert syndrome type 13 (TCTN1, AR)
  • Joubert syndrome type 14 (TMEM237, AR)
  • Joubert syndrome type 15 (CEP41, AR)
  • Joubert syndrome type 16 (TMEM138, AR)
  • Joubert syndrome type 17 (CPLANE1, AR)
  • Joubert syndrome type 18 (TCTN3, AR)
  • Joubert syndrome type 19 (ZNF423, AR)
  • Joubert syndrome type 2 (TMEM216, AR)
  • Joubert syndrome type 20 (TMEM231, AR)
  • Joubert syndrome type 21 (CSPP1, AR)
  • Joubert syndrome type 22 (PDE6D, AR)
  • Joubert syndrome type 23 (KIAA0586, AR)
  • Joubert syndrome type 3 (AHI1, AR)
  • Joubert syndrome type 4 (NPHP1, AR)
  • Joubert syndrome type 5 (CEP290, AR)
  • Joubert syndrome type 6 (TMEM67, AR)
  • Joubert syndrome type 7 (RPGRIP1L, AR)
  • Joubert syndrome type 8 (ARL13B, AR)
  • Joubert syndrome type 9 (CC2D2A, AR)
  • Joubert/Meckel syndrome phenotype (TCTN2, AR)
  • Joubert/nephronophthisis phenotype (ATXN10, AR)
  • Krabbe disease (GALC, AR)
  • Leukoencephalopathy with ataxia (CLCN2, AR)
  • Leukoencephalopathy with brainstem and spinal involvement and lactate elevation (DARS2, AR)
  • Marinesco-Sjogren syndrome (SIL1, AR)
  • Metachromatic leukodystrophy (ARSA, AR)
  • Mitochondrial recessive ataxia syndrome (POLG, AR)
  • Neurodegeneration with iron accumulation in the brain (PLA2G6, AR)
  • Neurodegeneration with iron accumulation in brain 1 (PANK2, AR)
  • Neuronal ceroid lipofuscinosis 5 (CLN5, AR)
  • Neuronal ceroid lipofuscinosis 6 (CLN6, AR)
  • Niemann-Pick disease, type C1 (NPC1, AR)
  • Niemann-Pick disease, type C2 (NPC2, AR)
  • Peroxisome biogenesis defect 5B (PEX2, AR)
  • Polymicrogyria, bilateral frontoparietal (ADGRG1, AR)
  • Polyneuropathy, ataxia, hearing loss, retinitis pigmentosa and cataract (ABHD12, AR)
  • Posterior column ataxia with retinitis pigmentosa (FLVCR1, AR)
  • Primary coenzyme Q10 deficiency type 4 (COQ8A, AR)
  • Pyruvate dehydrogenase E2 deficiency (DLAT, AR)
  • Salla disease (SLC17A5, AR)
  • Spastic ataxia (POLR3A, AR)
  • Spastic ataxia (SPG7, AR)
  • Spastic ataxia type 1 (VAMP1, AD)
  • Spastic ataxia type 2 (KIF1C, AR)
  • Spastic ataxia type 3 (MARS2, AR)
  • Spastic ataxia type 4 (MTPAP, AR)
  • Spastic ataxia type 5 (AFG3L2, AR)
  • Spastic ataxia, Charlevoix-Saguena type (SACS, AR)
  • Spastic paraplegia 76 (CAPN1, AR)
  • Wolfram syndrome (WFS1, AR)

 

Disorders are inherited in an autosomal dominant (AD), autosomal recessive (AR), X-linked (XL), or X-linked dominant (XLD) pattern.

 

For detailed information on ataxias and diagnostics, please visit our overview page ATAXIAS.

GENES

ABCB7, ABHD12, ADGRG1, AFG3L2, AHI1, AMACR, ARL13B, ARSA, ATCAY, ATM, ATP1A3, ATP8A2, ATXN10, BTD, CA8, CAPN1, CC2D2A, CEP290, CEP41, CLCN2, CLN5, CLN6, COQ8A, CP, CPLANE1, CSPP1, CYP27A1, DARS2, DLAT, DNAJC19, DNMT1, FLVCR1, GALC, GBA, GBA2, GJB1, GOSR2, INPP5E, KIAA0586, KIF1C, KIF7, MARS2, MRE11, MTPAP, NPC1, NPC2, NPHP1, OFD1, OPA1, OPA3, PANK2, PDE10A, PDE6D, PEX10, PEX2, PLA2G6, PNPLA6, POC1B, POLG, POLR3A, RPGRIP1L, SACS, SIL1, SLC17A5, SPG7, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, VAMP1, VLDLR, WFS1, ZNF423

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Mosaicism is a biological phenomenon in which a person has two or more genetically different sets of cells. Although mosaicism may have no effect, it...

Read more

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more